bleeding concerns about Avastin (bevacizumab)
August 2004
There are new bleeding concerns about Avastin (bevacizumab) used for metastatic colorectal cancer.
This specific topic you are searching for was not covered in the newsletter. As important new information is received, we want to provide our subscribers with it. As an extra service to our subscribers we are offering the Detail-Document.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote